References
1a
Cole C.
Foster AJ.
Freeman S.
Jaffar M.
Murray PE.
Stratford IJ.
Anti-Cancer Drug Des.
1999,
14:
383
1b
Gumina G.
Song GY.
Chu CK.
FEMS Microbiol. Lett.
2001,
202:
9
2a
Kappe CO.
Roschger PJ.
J. Heterocycl. Chem.
1989,
26:
55 ; and references cited therein
2b
Kappe CO.
Tetrahedron
1993,
49:
6937
3a
Mai A.
Marino A.
Sbardella G.
Massa S.
Loi AG.
Tramontano E.
Scano P.
La Colla P.
J. Med. Chem.
1995,
38:
3258
3b
Mai A.
Artico M.
Ragno R.
Sbardella G.
Massa S.
Musiu C.
Mura M.
Marturana F.
Cadeddu F.
Maga G.
La Colla P.
Bioorg. Med. Chem.
2005,
13:
2065
3c
Bajaj S.
Sambi SS.
Madan AK.
Bioorg. Med. Chem. Lett.
2005,
15:
467
3d
Ragno R.
Frasca S.
Manetti F.
Brizzi A.
Massa S.
J. Med. Chem.
2005,
48:
200
3e
Botta M.
Occhionero F.
Nicoletti R.
Mastromarino P.
Conti C.
Magrini M.
Saladino R.
Bioorg. Med. Chem.
1999,
7:
1925
4
Yuskovets VN.
Ivin BA.
Tetrahedron Lett.
2003,
44:
5279
5a
Brown DJ. In
Comprehensive Heterocyclic Chemistry
Vol. 3:
Katritzky AR.
Rees CW.
Pergamon;
Oxford:
1984.
5b
Sarabia F.
Martin-Ortiz L.
Lopez-Herrera FJ.
Org. Biomol. Chem.
2003,
1:
3716
5c
Malik V.
Singh P.
Kumar S.
Tetrahedron
2005,
61:
4009
5d
Friot C.
Reliquet A.
Reliquet F.
Meslin JC.
Synthesis
2000,
695
5e
Landreau C.
Deniaud D.
Reliquet A.
Reliquet F.
Meslin JC.
J. Heterocycl. Chem.
2001,
38:
93
6a
Joule JA.
Mills K.
In Heterocyclic Chemistry
4th ed.:
Mead O.
Blackwell Science;
Oxford:
2000.
6b
Stanovnik B.
Svete J.
Chem. Rev.
2004,
104:
2433
7
Hronowski LJJ.
Szarek WA.
Can. J. Chem.
1985,
63:
2787
8a
Jayakumar S.
Ishar MPS.
Mahajan MP.
Tetrahedron
2002,
58:
379
8b
Abbiati G.
Cirrincione de Carvalho A.
Rossi E.
Tetrahedron
2003,
59:
7397
8c
Mohan C.
Kumar V.
Mahajan MP.
Tetrahedron Lett.
2004,
45:
6075
8d
Jayakumar S.
Singh P.
Mahajan MP.
Tetrahedron
2004,
60:
4315
8e
Landreau C.
Deniaud D.
Meslin JC.
J. Org. Chem.
2003,
68:
4912
8f
Landreau C.
Deniaud D.
Reliquet A.
Meslin JC.
Eur. J. Org. Chem.
2003,
3:
421
9
Pearson MSM.
Robin A.
Bourgougnon N.
Meslin JC.
Deniaud D.
J. Org. Chem.
2003,
68:
8583
10
Herrera A.
Martinez-Alvarez R.
Ramiro P.
Tetrahedron
2003,
59:
7331
11a
Robin A.
Meslin JC.
Deniaud D.
Synthesis
2004,
1633
11b
Robin A.
Julienne K.
Meslin JC.
Deniaud D.
Tetrahedron Lett.
2004,
45:
9557
12
Methylsulfanylpyrimidinethiones 3.
Isothiocyanate (2.2 mmol) was added to a solution of diazadienium iodide 1 (272 mg, 1.0 mmol) in CH2Cl2 (10 mL). After 15 min, Et3N (300 µL, 2.2 mmol) was added and the reaction mixture was stirred at r.t. over a period of 4 h for 3a and 4 h for 3b. Then, the organic mixture was washed twice with H2O, dried over MgSO4 and concentrated under vacuum. The residue was purified by chromatography on silica gel (CH2Cl2-PE-Et3N, 50:47:3).
Spectroscopic data of compound 3a: IR (KBr): ν = 1605, 1589, 1481, 1405, 1323, 1175 cm-1. 1H NMR (200 MHz, CDCl3): δ = 2.66 (s, 3 H, CH
3S), 6.60 (d, 1 H, 3
J = 7.0 Hz, CH-5), 7.40 (m, 5 H, 5 × CH
ar), 7.43 (d, 1 H, 3
J = 7.0 Hz, CH-6). 13C NMR (50 MHz, CDCl3): δ = 13.2 (CH3S), 107.7 (CH-5), 126.6 (2 × CHar), 129.3 (CHar), 129.9 (2 × CHar), 144.0 (2 C, CH-6 and C
ar), 173.4 (C-4), 182.0 (CS). Mp 173-175 °C. HRMS (ESI+): m/z calcd for C11H10N2S2Na [M + Na]+: 257.0183; found: 257.0182.
13a
Hori M.
Kataoka T.
Shimizu H.
Imai E.
Yokomoto M.
Ando Y.
Synthesis
1987,
278
13b
Tea-Gokou C.
Pradère JP.
Bujoli B.
Quiniou H.
Toupet L.
Bull. Soc. Chim. Fr.
1987,
1:
149
13c
Zigeuner G.
Schweiger K.
Fuchsgruber A.
Monatsh. Chem.
1981,
112:
187
14a
Masuda R.
Hojo M.
Ichii T.
Sasano S.
Kobayashi T.
Kuroda C.
Tetrahedron Lett.
1991,
32:
1195
14b
Mohammadpoor-Baltork I.
Khodaei MM.
Nikoofar K.
Tetrahedron Lett.
2003,
44:
591
15a
Mohammadpoor-Baltork I.
Sadeghi MM.
Esmayilpour K.
Phosphorus, Sulfur Silicon Relat. Elem.
2003,
178:
61
15b
Greenhalgh RP.
Synlett
1992,
235
16
Methylthiouracils 6.
Oxone® (1.23 g, 2.0 mmol) and wet alumina (1.0 g) were added to a solution of methylsulfanylpyrimidinethiones (1.0 mmol) in CH2Cl2 (15 mL). The reaction mixture was stirred at r.t. for 48 h. Then, the inorganic salts were removed by filtration and the filtrate was concentrated under vacuum. The residue was purified by chromatography on silica gel (CH2Cl2-PE-Et3N, 90:7:3).
Spectroscopic data of compound 6a: IR (KBr): ν = 1664, 1614, 1493, 1287 cm-1. 1H NMR (200 MHz, CDCl3): δ = 2.52 (s, 3 H, CH
3S), 6.22 (d, 1 H, 3
J = 7.0 Hz, CH-5), 7.28 (m, 6 H, 5 × CH
ar and CH-6). 13C NMR (50 MHz, CDCl3): δ = 13.0 (CH3S), 103.7 (CH-5), 126.1 (2 × CHar), 128.7 (CHar), 129.5 (2 × CHar), 140.3 (C
ar), 144.0 (CH-6), 153.9 (CO), 178.6 (C-4). Mp 156-158 °C. HRMS (ESI+): m/z calcd for C11H10N2OSNa [M + Na]+: 241.0412; found: 241.0410.
17 Spectroscopic data of compound 7b: IR (KBr): ν = 1742, 1734, 1719, 1630, 1325, 1109 cm-1. 1H NMR (400 MHz, DMSO-d
6): δ = 3.25 (s, 3 H, CH
3N), 6.22 (d, 1 H, 3
J = 6.8 Hz, CH-5), 7.53 (d, 1 H, 3
J = 6.8 Hz, CH-6). 13C NMR (50 MHz, DMSO-d
6): δ = 36.0 (CH3N), 111.7 (CH-5), 142.4 (CH-6), 148.8 (CO), 190.1 (CS). Mp 193-196 °C. HRMS (ESI+): m/z calcd for C5H6N2SONa [M + Na]+: 165.0099; found: 165.0098.
Spectroscopic data of compound 8b: IR (KBr): ν = 1695, 1423, 1379, 1331. 1H NMR (400 MHz, DMSO-d
6): δ = 3.21 (s, 3 H, CH
3N), 5.51 (d, 1 H, 3
J = 8.0 Hz, CH-5), 7.60 (d, 1 H, 3
J = 8.0 Hz, CH-6). 13C NMR (50 MHz, DMSO-d
6): δ = 34.4 (CH3N), 99.7 (CH-5), 145.6 (CH-6), 150.5 (CO-2), 163.1 (CO-4). Mp 229-234 °C. HRMS (ESI+): m/z calcd for C5H6N2O2Na [M + Na]+: 149.0327; found: 149.0325.